LRG1通过破坏骨髓原始细胞调节来推动AML的进展
Rongxia Guo1, Peng Wu2, Shuxin Yao3
1Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, People's Republic of China.
Blood and lymphatic cancer : targets and therapy
|December 24, 2025
概括
富含白的α-2-糖蛋白1 (LRG1) 在急性髓性白血病 (AML) 中升高,与预后不佳和驱动疾病进展相关. 准LRG1为AML提供了一个有希望的治疗策略.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 急性髓性白血病 (AML) 由于其分子复杂性和患者的不良结果,提出了重大临床挑战.
- 对于新的生物标志物和治疗标来提高AML治疗疗效的需求至关重要.
研究的目的:
- 研究白丰富的α-2-糖蛋白1 (LRG1) 在AML中的作用.
- 评估LRG1作为潜在的预后生物标志物和AML的治疗点.
主要方法:
- 在AML患者样本与对照中的LRG1表达的综合分析.
- 评估LRG1与临床因素,突变和亚型的相关性.
- 在AML模型中使用LRG1淘汰的功能性研究.
- 单细胞RNA分析,以确定LRG1表达细胞群和微环境相互作用.
主要成果:
- 在AML患者中,LRG1表达显著增加,并在治疗后减少.
- 升高的LRG1与FLT3突变,特定的AML亚型 (M3-M5) 和降低的存活率相关.
- LRG1敲击损害了细胞生长,增加了细胞亡,并破坏了分化.
- LRG1丰富于造血干细胞和原始细胞,通过MIF,GALECTIN和CypA.中介交叉通讯.
结论:
- 在AML中,LRG1作为可靠的预后生物标志物.
- LRG1通过调节髓状细胞原始体的失调,在AML的发病过程中发挥着关键的功能作用.
- LRG1代表了新的AML治疗策略的有前途的治疗标.
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
3.9K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.9K
Lineage Commitment
4.0K
Commitment is the process whereby stem cells:
4.0K
Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K


